Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

ClinicalTrials.gov ID: NCT00366002

Public ClinicalTrials.gov record NCT00366002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Open-Label, Non-Randomized, Multicenter Study to Evaluate the Patient's Perception of Outcome After Treatment With Darifenacin in Overactive Bladder (OAB) Patients Dissatisfied With Prior Anticholinergic Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate safety, efficacy and patient's perception of outcome after treatment with darifenacin (7.5 mg once daily (o.d.) with voluntary increase up to 15 mg o.d.) in patients with OAB who are dissatisfied with prior oxybutynin extended release (ER) or tolterodine extended release (ER) therapy.

Study identification

NCT ID
NCT00366002
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
Not listed
Completion
Sep 2007 (Actual)
Last update posted
Jan 15, 2008

2006 – 2007

United States locations

U.S. sites
82
U.S. states
25
U.S. cities
82
Facility City State ZIP Site status
Investigative Site Birmingham Alabama 35242 —
Investigative Site Chandler Arizona 85224 —
Investigative Site Mesa Arizona 85206 —
Investigative Site Sierra Vista Arizona 85635 —
Investigative Site Tempe Arizona 85282 —
Investigative Site Atherton California 94027 —
Investigative Site Los Angeles California 90048 —
Investigative Site Newport Beach California 92660 —
Investigative Site San Diego California 92108 —
Investigative Site Temecula California 92591 —
Investigative Site Torrance California 90505 —
Investigative Site Upland California 91786 —
Investigative Site Aurora Colorado 80012 —
Investigative Site Littleton Colorado 80122 —
Investigative Site Wheat Ridge Colorado 80033 —
Investigative Site Hollywood Florida 33021 —
Investigative Site New Smyrna Beach Florida 32168 —
Investigative Site Ocala Florida 34474 —
Investigative Site Orlando Florida 32803 —
Investigative Site Sarasota Florida 34237 —
Investigative Site Tampa Florida 33607 —
Investigative Site West Palm Beach Florida 33409 —
Investigative Site Weston Florida 33331 —
Investigative Site Alpharetta Georgia 30005 —
Investigative Site Atlanta Georgia 30342 —
Investigative Site Marietta Georgia 30060 —
Investigative Site Roswell Georgia 30076 —
Investigative Site Snellville Georgia 30078 —
Investigative Site Melrose Park Illinois 60160 —
Investigative Site O'Fallon Illinois 62269 —
Investigative Site Peoria Illinois 61615 —
Investigative Site Evansville Indiana 47714 —
Investigative Site Greenwood Indiana 46143 —
Investigative Site Topeka Kansas 66606 —
Investigative Site Milford Massachusetts 01757 —
Investigative Site Watertown Massachusetts 02472 —
Investigative Site Flint Michigan 48507 —
Investigative Site Saint Joseph Michigan 49085 —
Investigative Site Chesterfield Missouri 63017 —
Investigative Site Kansas City Missouri 64114 —
Investigative Site St Louis Missouri 63136 —
Investigative Site Lincoln Nebraska 68510 —
Investigative Site Omaha Nebraska 68114 —
Investigative Site Lawrenceville New Jersey 08648 —
Investigative Site West Orange New Jersey 07052 —
Investigative Site Albany New York 12206 —
Investigative Site Garden City New York 11530 —
Investigative Site Latham New York 12110 —
Investigative Site Mineola New York 11501 —
Investigative Site New Hartford New York 13413 —
Investigative Site Poughkeepsie New York 12601 —
Investigative Site Troy New York 12180 —
Investigative Site Williamsville New York 14221 —
Investigative Site Burlington North Carolina 27215 —
Investigative Site Charlotte North Carolina 28209 —
Investigative Site Concord North Carolina 28205 —
Investigative Site Hickory North Carolina 28601 —
Investigative Site High Point North Carolina 27262 —
Investigative Site Salisbury North Carolina 28144 —
Investigative Site Winston-Salem North Carolina 27103 —
Investigative Site Cincinnati Ohio 45212 —
Investigative Site Bethany Oklahoma 73008 —
Investigative Site Edmond Oklahoma 73034 —
Investigative Site Portland Oregon 97205 —
Investigative Site Springfield Oregon 97477 —
Investigative Site Pittsburgh Pennsylvania 15213 —
Investigative Site Amarillo Texas 79106 —
Investigative Site Corsicana Texas 75110 —
Investigative Site Dallas Texas 75231 —
Investigative Site Fort Worth Texas 76104 —
Investigative Site Houston Texas 77005 —
Investigative Site Lake Jackson Texas 77566 —
Investigative Site Bountiful Utah 84010 —
Investigative Site Salt Lake City Utah 84124 —
Investigative Site Sandy City Utah 84070 —
Investigative Site Richmond Virginia 23294 —
Investigative Site Everett Washington 98208 —
Investigative Site Lakewood Washington 98499 —
Investigative Site Mountlake Terrace Washington 98233 —
Investigative Site Seattle Washington 98101 —
Investigative Site Vancouver Washington 98664 —
Investigative Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00366002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2008 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00366002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →